Fig. 2. (A) Comparison of post-transplant patient survival between the metabolic liver disease (MLD) group (n=23) and the non-MLD group (n=220) in the pediatric age group. (B) Comparison of the post-transplant patient survival among the living donor types (haplo-matched donors [n=18], unrelated donors [n=17], mixed donors [n=7]). (C) Comparison of the post-transplant patient survival between the living donors (n=42) and the cadaveric donors (n=12).
